Published in Semin Pediatr Surg on August 01, 2005
Necrotizing enterocolitis: a multifactorial disease with no cure. World J Gastroenterol (2008) 1.46
New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond. Pediatr Res (2011) 1.36
Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology (2009) 1.23
The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech (2008) 1.10
Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest (2011) 1.08
Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg (2010) 1.07
Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res (2009) 1.01
Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis. J Pediatr Surg (2010) 0.95
Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes. Growth Factors (2010) 0.91
Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg (2012) 0.91
Pathogenesis of neonatal necrotizing enterocolitis. Pediatr Surg Int (2015) 0.86
Heparin-binding EGF-like growth factor protects pericytes from injury. J Surg Res (2010) 0.84
Interferon-gamma inhibits enterocyte migration by reversibly displacing connexin43 from lipid rafts. Am J Physiol Gastrointest Liver Physiol (2008) 0.84
Insights into virulence factors determining the pathogenicity of Cronobacter sakazakii. Virulence (2015) 0.83
One-dimensional elastic continuum model of enterocyte layer migration. Biophys J (2007) 0.83
Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects. Pathophysiology (2013) 0.81
Heparin-binding EGF-like growth factor (HB-EGF) promotes cell migration and adhesion via focal adhesion kinase. J Surg Res (2014) 0.80
The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg (2013) 0.78
Pathogenesis of NEC: Role of the innate and adaptive immune response. Semin Perinatol (2016) 0.75
Are EGF and TLR-4 crucial to understanding the link between milk and NEC? Mucosal Immunol (2015) 0.75
Dextran sodium sulfate (DSS) induces necrotizing enterocolitis-like lesions in neonatal mice. PLoS One (2017) 0.75
Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest (2002) 2.40
Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis. J Pediatr (2007) 1.54
HB-EGF protects the lungs after intestinal ischemia/reperfusion injury. J Surg Res (2010) 1.51
HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology (2005) 1.49
Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg (2006) 1.42
HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors (2007) 1.35
Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology (2009) 1.23
Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma. Cancer (2005) 1.17
Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res (2007) 1.16
Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2007) 1.15
Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg (2003) 1.13
HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors (2008) 1.12
Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg (2008) 1.11
Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice. J Pediatr Surg (2008) 1.11
Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest (2011) 1.08
Can we cut the incidence of necrotizing enterocolitis in half--today? Fetal Pediatr Pathol (2010) 1.08
Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg (2010) 1.07
Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice. Surgery (2009) 1.04
Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal (2002) 1.04
Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia/reperfusion injury. J Invest Surg (2003) 1.02
Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2006) 1.01
Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res (2009) 1.01
Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil (2002) 0.99
Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor. J Immunol (2003) 0.97
Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury. Semin Pediatr Surg (2004) 0.97
Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Pediatr Surg (2002) 0.97
Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis. J Pediatr Surg (2010) 0.95
Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells. Nitric Oxide (2002) 0.94
Endothelin-1 in human intestine resected for necrotizing enterocolitis. J Pediatr (2005) 0.94
Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice. Lab Invest (2012) 0.93
Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats. Peptides (2005) 0.92
Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy. Stem Cell Res Ther (2013) 0.91
Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes. Growth Factors (2010) 0.91
Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg (2012) 0.91
The pediatric burn unit: a profit center. J Pediatr Surg (2004) 0.90
Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury. J Pediatr Surg (2013) 0.89
HB-EGF promotes intestinal restitution by affecting integrin-extracellular matrix interactions and intercellular adhesions. Growth Factors (2013) 0.89
Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg (2006) 0.88
A silver impregnated antimicrobial dressing reduces hospital length of stay for pediatric patients with burns. J Burn Care Res (2007) 0.88
Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway. J Immunol (2005) 0.88
A silver-impregnated antimicrobial dressing reduces hospital costs for pediatric burn patients. J Pediatr Surg (2007) 0.87
Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation. Surgery (2010) 0.87
Innate immune function predicts the development of nosocomial infection in critically injured children. Shock (2014) 0.86
Heparin-binding EGF-like growth factor decreases neutrophil-endothelial cell interactions. J Surg Res (2007) 0.86
Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles. Microvasc Res (2009) 0.85
Heparin-binding EGF-like growth factor protects pericytes from injury. J Surg Res (2010) 0.84
The role of the intestinal microcirculation in necrotizing enterocolitis. Semin Pediatr Surg (2013) 0.84
Gastric outlet obstruction due to adenocarcinoma in a patient with Ataxia-Telangiectasia syndrome: a case report and review of the literature. World J Surg Oncol (2009) 0.83
Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells. Neurosignals (2010) 0.81
HB-EGF improves intestinal microcirculation after hemorrhagic shock. J Surg Res (2010) 0.81
Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury. J Pediatr Surg (2005) 0.81
Heparin-binding epidermal growth factor-like growth factor promotes murine enteric nervous system development and enteric neural crest cell migration. J Pediatr Surg (2012) 0.80
Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury. J Pediatr Surg (2013) 0.80
Heparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis. Surgery (2012) 0.80
Heparin-binding epidermal growth factor-like growth factor protects mesenchymal stem cells. J Surg Res (2012) 0.79
Extracorporeal membrane oxygenation as a lifesaving modality in the treatment of pediatric patients with burns and respiratory failure. J Pediatr Surg (2010) 0.78
Prevalence and correlates of posttraumatic stress in parents of young children postburn. J Burn Care Res (2013) 0.78
Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. J Surg Res (2010) 0.78
Poly(ADP-ribose) polymerase-1: a novel therapeutic target in necrotizing enterocolitis. Pediatr Res (2011) 0.78
Scaffolding for challenging environments: materials selection for tissue engineered intestine. J Biomed Mater Res A (2013) 0.78
A technique for systemic mesenchymal stem cell transplantation in newborn rat pups. J Invest Surg (2012) 0.77
Inversion appendectomy acting as a lead point for intussusception. Pediatr Surg Int (2008) 0.77
Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA. Growth Factors (2005) 0.77
Intestinal O2 consumption in necrotizing enterocolitis: role of nitric oxide. Pediatr Res (2006) 0.76
Diffuse intestinal ganglioneuromatosis in a child. J Pediatr Surg (2013) 0.75
Stem cell therapy for necrotizing enterocolitis: innovative techniques and procedures for pediatric translational research. Methods Mol Biol (2014) 0.75
Profiles in surgical research: Michael R. Harrison, MD, FACS. Bull Am Coll Surg (2015) 0.75
Profiles in surgical research: Michael T. Longaker, MD, MBA, FACS. Bull Am Coll Surg (2015) 0.75
Respiratory failure after pediatric scald injury. J Pediatr Surg (2011) 0.75
Effects of lipopolysaccharide-induced inflammation on the interstitial cells of Cajal. Cell Tissue Res (2014) 0.75
An unusual case of foreign body pulmonary embolus: case report and review of penetrating trauma at a pediatric trauma center. Pediatr Surg Int (2015) 0.75
Development and implementation of an electronic health record generated surgical handoff and rounding tool. J Med Syst (2015) 0.75
Myectomy-myotomy for long segment Hirschsprung's disease in a patient with Haddad syndrome. J Pediatr Surg (2009) 0.75
Profiles in surgical research: Dorry L. Segev, MD, PhD, FACS. Bull Am Coll Surg (2015) 0.75
Delaying Appendectomy Does Not Lead to Higher Rates of Surgical Site Infections: A Multi-institutional Analysis of Children With Appendicitis. Ann Surg (2016) 0.75
Pygopagus Conjoined Twins: A Neurophysiologic Intraoperative Monitoring Schema. J Clin Neurophysiol (2016) 0.75